-
Je něco špatně v tomto záznamu ?
MiR-301a-3p Suppresses Estrogen Signaling by Directly Inhibiting ESR1 in ERα Positive Breast Cancer
S. Lettlova, V. Brynychova, J. Blecha, D. Vrana, M. Vondrusova, P. Soucek, J. Truksa,
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
Grantová podpora
NV17-28470A
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
NLK
Directory of Open Access Journals
od 2013
Free Medical Journals
od 2005
ProQuest Central
od 2016-05-01 do 2019-01-31
Open Access Digital Library
od 2013-01-01
Medline Complete (EBSCOhost)
od 2005-01-01
Health & Medicine (ProQuest)
od 2016-05-01 do 2019-01-31
Karger Open Access
od 2013-01-01 do 2018-12-31
ROAD: Directory of Open Access Scholarly Resources
od 1991
PubMed
29763890
DOI
10.1159/000489687
Knihovny.cz E-zdroje
- MeSH
- 3' nepřekládaná oblast MeSH
- alfa receptor estrogenů analýza genetika metabolismus MeSH
- estrogeny metabolismus MeSH
- lidé MeSH
- mikro RNA genetika MeSH
- myši inbrední BALB C MeSH
- myši nahé MeSH
- nádorové buněčné linie MeSH
- nádory prsu genetika metabolismus patologie MeSH
- regulace genové exprese u nádorů * MeSH
- signální transdukce MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND/AIMS: MiRNA-301a-3p is an oncogenic miRNA whose expression is associated with tumor development, metastases and overall poor prognosis. Estrogen receptor α (ERα) is one of the estrogen hormone-activated transcription factors, which regulates a large number of genes and is involved in the mammary gland development. Expression of ERα is considered to be a good indicator for endocrine therapy and breast cancer survival. Loss of ERα in breast cancer patients indicates invasiveness and poor prognosis. In this study, we focus on the regulation of ERα by miR-301a and its role in transition from estrogen-dependent to estrogen-independent breast cancer. METHODS: Expression of miR-301a-3p was measured by qRT-PCR in tumor tissue samples from 111 patients with primary breast carcinoma and in mammospheres representing in vitro model of cancer stem-like cells. Dual reporter luciferase assay and complementary experiments were performed to validate ESR1 as a direct target of miR-301a-3p. The effect of miR-301a-3p on estrogen signaling was evaluated on the level of gene and protein expression and growth response to estrogens. Finally, the effect of miR-301a-3p expression on tumor growth was studied in nude mice. RESULTS: We identified ESR1 as a direct target of miR-301a-3p. Ectopic miR-301a-3p causes a decrease in ESR1 mRNA and protein level and modulates the expression of ERα target genes in ERα positive breast cancer cells. Consistently, miR-301a-3p causes a decrease in sensitivity of MCF7 cells to 17β-estradiol and inhibits the growth of estrogen dependent tumor in nude mice. Yet, the mice tumors have significantly increased expression of genes related to cancer stem-like cells and epithelial to mesenchymal transition suggesting enrichment of the population of cells with more invasive properties, in line with our observation that miR-301a-3p expression is highly increased in mammospheres which show a decrease in estrogenic signaling. Importantly, miR-301a-3P level is also increased in primary breast cancer samples exhibiting an ER/PR negative phenotype. CONCLUSION: Our results confirm ESR1 as a direct target of miR-301a-3p and suggest that miR-301a-3p likely contributes to development of estrogen independence, which leads to a more invasive phenotype of breast cancer.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18033082
- 003
- CZ-PrNML
- 005
- 20181023105527.0
- 007
- ta
- 008
- 181008s2018 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1159/000489687 $2 doi
- 035 __
- $a (PubMed)29763890
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Lettlova, Sandra $u Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV Research Center, Prague, Czech Republic. Faculty of Science, Charles University, Prague, Czech Republic.
- 245 10
- $a MiR-301a-3p Suppresses Estrogen Signaling by Directly Inhibiting ESR1 in ERα Positive Breast Cancer / $c S. Lettlova, V. Brynychova, J. Blecha, D. Vrana, M. Vondrusova, P. Soucek, J. Truksa,
- 520 9_
- $a BACKGROUND/AIMS: MiRNA-301a-3p is an oncogenic miRNA whose expression is associated with tumor development, metastases and overall poor prognosis. Estrogen receptor α (ERα) is one of the estrogen hormone-activated transcription factors, which regulates a large number of genes and is involved in the mammary gland development. Expression of ERα is considered to be a good indicator for endocrine therapy and breast cancer survival. Loss of ERα in breast cancer patients indicates invasiveness and poor prognosis. In this study, we focus on the regulation of ERα by miR-301a and its role in transition from estrogen-dependent to estrogen-independent breast cancer. METHODS: Expression of miR-301a-3p was measured by qRT-PCR in tumor tissue samples from 111 patients with primary breast carcinoma and in mammospheres representing in vitro model of cancer stem-like cells. Dual reporter luciferase assay and complementary experiments were performed to validate ESR1 as a direct target of miR-301a-3p. The effect of miR-301a-3p on estrogen signaling was evaluated on the level of gene and protein expression and growth response to estrogens. Finally, the effect of miR-301a-3p expression on tumor growth was studied in nude mice. RESULTS: We identified ESR1 as a direct target of miR-301a-3p. Ectopic miR-301a-3p causes a decrease in ESR1 mRNA and protein level and modulates the expression of ERα target genes in ERα positive breast cancer cells. Consistently, miR-301a-3p causes a decrease in sensitivity of MCF7 cells to 17β-estradiol and inhibits the growth of estrogen dependent tumor in nude mice. Yet, the mice tumors have significantly increased expression of genes related to cancer stem-like cells and epithelial to mesenchymal transition suggesting enrichment of the population of cells with more invasive properties, in line with our observation that miR-301a-3p expression is highly increased in mammospheres which show a decrease in estrogenic signaling. Importantly, miR-301a-3P level is also increased in primary breast cancer samples exhibiting an ER/PR negative phenotype. CONCLUSION: Our results confirm ESR1 as a direct target of miR-301a-3p and suggest that miR-301a-3p likely contributes to development of estrogen independence, which leads to a more invasive phenotype of breast cancer.
- 650 _2
- $a 3' nepřekládaná oblast $7 D020413
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a nádory prsu $x genetika $x metabolismus $x patologie $7 D001943
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a alfa receptor estrogenů $x analýza $x genetika $x metabolismus $7 D047628
- 650 _2
- $a estrogeny $x metabolismus $7 D004967
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a regulace genové exprese u nádorů $7 D015972
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a myši inbrední BALB C $7 D008807
- 650 _2
- $a myši nahé $7 D008819
- 650 _2
- $a mikro RNA $x genetika $7 D035683
- 650 _2
- $a signální transdukce $7 D015398
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Brynychova, Veronika $u Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic. Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Olomouc, Czech Republic.
- 700 1_
- $a Blecha, Jan $u Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV Research Center, Prague, Czech Republic.
- 700 1_
- $a Vrana, David $u Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic. Department of Oncology, Palacky University Medical School and Teaching Hospital, Olomouc, Czech Republic.
- 700 1_
- $a Vondrusova, Magdalena $u Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV Research Center, Prague, Czech Republic.
- 700 1_
- $a Soucek, Pavel $u Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic. Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Olomouc, Czech Republic.
- 700 1_
- $a Truksa, Jaroslav $u Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV Research Center, Prague, Czech Republic.
- 773 0_
- $w MED00173244 $t Cellular physiology and biochemistry international journal of experimental cellular physiology, biochemistry, and pharmacology $x 1421-9778 $g Roč. 46, č. 6 (2018), s. 2601-2615
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29763890 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20181008 $b ABA008
- 991 __
- $a 20181023110034 $b ABA008
- 999 __
- $a ok $b bmc $g 1340792 $s 1030076
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 46 $c 6 $d 2601-2615 $e 20180507 $i 1421-9778 $m Cellular physiology and biochemistry $n Cell Physiol Biochem $x MED00173244
- GRA __
- $a NV17-28470A $p MZ0
- LZP __
- $a Pubmed-20181008